Rapid Micro Biosystems (RPID) Return on Capital Employed (2021 - 2026)
Rapid Micro Biosystems recorded quarterly Return on Capital Employed of 100.19% in Q1 2026, down 29.26% quarter-over-quarter from 77.51% in Q4 2025, and down 3860.0% year-over-year from 2.66% in Q1 2025.
Rapid Micro Biosystems' Return on Capital Employed history runs 6 years deep, the most recent figure standing at 100.19% for Q1 2026.
- In Q1 2026, Return on Capital Employed fell 3860.0% year-over-year to 100.19%; the TTM figure through Mar 2026 stood at 100.19% (down 3860.0% YoY), while the FY2025 annual figure was 69.67%, down 2132.0% from the prior year.
- Return on Capital Employed came in at 100.19% for Q1 2026 at Rapid Micro Biosystems, down from 77.51% in the prior quarter.
- In the past five years, Return on Capital Employed ranged from a high of 23.8% in Q1 2022 to a low of 100.19% in Q1 2026.
- A 5-year average of 51.71% and a median of 46.64% in 2024 frame the typical range for Return on Capital Employed.
- Across the five-year window, Return on Capital Employed plunged 688 bps in 2022 and sank 3860 bps in 2026, its largest moves.
- Rapid Micro Biosystems' Return on Capital Employed stood at 35.67% in 2022, then slipped by 24 bps to 44.25% in 2023, then sank by 34 bps to 59.12% in 2024, then sank by 31 bps to 77.51% in 2025, then declined by 29 bps to 100.19% in 2026.
- According to Business Quant data, Return on Capital Employed over the past three periods registered 100.19%, 77.51%, and 71.57% for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 9.61% |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 12.24% |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 7.36% |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 9.62% |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 11.13% |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 7.62% |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 24.24% |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 9.30% |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 11.57% |
| 10 | Rapid Micro Biosystems | 89.50 Mn | 66.56 Mn | 371,000.00 | -100.19% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -100.19% |
| Dec 31, 2025 | -77.51% |
| Sep 30, 2025 | -71.57% |
| Jun 30, 2025 | -71.88% |
| Mar 31, 2025 | -61.59% |
| Dec 31, 2024 | -59.12% |
| Sep 30, 2024 | -54.30% |
| Jun 30, 2024 | -51.31% |
| Mar 31, 2024 | -46.64% |
| Dec 31, 2023 | -44.25% |
| Sep 30, 2023 | -44.04% |
| Jun 30, 2023 | -41.96% |
| Mar 31, 2023 | -37.49% |
| Dec 31, 2022 | -35.67% |
| Sep 30, 2022 | -31.22% |
| Jun 30, 2022 | -26.50% |
| Mar 31, 2022 | -23.80% |
| Dec 31, 2021 | -20.57% |
| Sep 30, 2021 | -24.35% |